3-(1H-Indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione, 98.0%, 50mg

9,10-Bis[N,N-di(p-tolyl)amino]anthracene>98.0%(HPLC)200mg

5-Fluoro-2-methoxy-3-nitroacetophenone, 25g

3-(1H-1,2,3-Triazol-1-yl)aniline, 95%, 1g

2-Chloro-6-methylpyrimidine-4-carbonitrile, 95.0%, 1g

1-(3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)-3-(methylthio)propan-1-amine, 95.0%, 250mg

2-CHLORO-1-(6-CHLOROPYRIDIN-3-YL)ETHANONE, 95.0%, 100mg

1-(3-Fluorophenyl)cyclohexane-1-carboxylic acid, 98%, 500mg

N-Methyl-N-trimethylsilyltrifluoroacetamide [Trimethylsilylating Agent]>95.0%(GC)25mL

2-(4-(2-Hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one, 95.0%, 100mg

2-(1H-tetrazol-5-yl)aniline hydrate, 95.0%, 1g

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1), 99%, 10mg

6-Chloro-9-(tetrahydropyran-2-yl)-9H-purine, 95.0%, 25g